Replies to post #173273 on Biotech Values

[jq1234]

This type of study is enrolled by cohort, no reason they can't stop enrolling MF cohorts (3 cohorts plus 28 expanded patients already) while keeping AML/MDS cohorts open according to protocol. This happens all the time. Your reasoning is least likely scenario.